Description
A potent and selective agonist of ERβ (Ki = 1.54 nM; EC50 = 3.61 nM); reduces the viability of patient-derived, ERβ+ primary GBM cells; reduces in vitro colony formation and induces apoptosis; induces G2/M arrest and sensitizes GBM cells to chemotherapeutic agents in vitro; reduces GBM progression in and increases survival of orthotopic and syngeneic GBM mouse models; induces dose-dependent reduction in prostate weight with no effect on levels of circulating testosterone or dihydrotestosterone in a rat model of BPH
Formal name: (3aS,4R,9bR)-1,2,3,3a,4,9b-hexahydro-4-(4-hydroxyphenyl)-cyclopenta[c][1]benzopyran-8-ol
Synonyms: LY500307
Molecular weight: 282.3
CAS: 533884-09-2
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Cancer|Cell Cycle|G2/M||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Endocrinology & Metabolism|Hormones & Receptors|Estrogens & Progestins